Douglas Unwin

Vorstandsvorsitzender bei GEOLOGICA RESOURCE CORP.

Vermögen: 58 352 $ am 31.05.2024

64 Jahre

Consumer Services

Non-Energy Minerals

Health Technology

Aktive Positionen von Douglas Unwin

Unternehmen	Position	Beginn	Ende
GEOLOGICA RESOURCE CORP.	Direktor/Vorstandsmitglied	-	-
	Vorstandsvorsitzender	22.05.2018	-
	Präsident	12.09.2016	-
	Vorsitzender	12.09.2016	-
DARK STAR MINERALS INC.	Direktor/Vorstandsmitglied	02.06.2023	-
WEEKAPAUG LITHIUM LIMITED	Direktor/Vorstandsmitglied	-	-

Unternehmen	Position	Beginn	Ende
Pacific Therapeutics Ltd. Pacific Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada.	Direktor/Vorstandsmitglied	12.09.2005	25.08.2015
	Vorstandsvorsitzender	12.09.2005	25.08.2015
	Gründer	12.09.2005	25.08.2015
	Investor Relations Kontakt	12.09.2005	25.08.2015
	Präsident	12.09.2005	25.08.2015
Neuro Discovery, Inc.	Corporate Officer/Principal	-	-
MANY BRIGHT IDEAS TECHNOLOGIES INC.	Vorstandsvorsitzender	-	-

University of Saskatchewan	Masters Business Admin
University of British Columbia	Undergraduate Degree

International

Kanada	8
	2

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
GEOLOGICA RESOURCE CORP.	Non-Energy Minerals
MANY BRIGHT IDEAS TECHNOLOGIES INC.	Health Services
DARK STAR MINERALS INC.	Non-Energy Minerals

Private Unternehmen	3
Pacific Therapeutics Ltd. Pacific Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada.	Health Technology
Neuro Discovery, Inc.	Commercial Services
Weekapaug Lithium Ltd.